MedPath

GLYXAMBI 10 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

GLYXAMBI 10 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

1161146005

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jul 10, 2017

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1161146005
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (2)

EMPAGLIFLOZINAActive
Quantity: 10 mg
Name: EMPAGLIFLOZINA
LINAGLIPTINAActive
Quantity: 5 mg
Name: LINAGLIPTINA

ATC CLASSIFICATION (3)

A10B
A10BD
A10BD19

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.